Brokerages Anticipate RTI Surgical, Inc. (RTIX) to Announce $0.03 Earnings Per Share
RTI Surgical, Inc. (NASDAQ:RTIX) has been given an average broker rating score of 3.00 (Hold) from the three brokers that provide coverage for the company, Zacks Investment Research reports. Three equities research analysts have rated the stock with a hold recommendation.
Analysts have set a 12 month consensus target price of $5.00 for the company and are predicting that the company will post $0.03 earnings per share for the current quarter, according to Zacks. Zacks has also given RTI Surgical an industry rank of 168 out of 265 based on the ratings given to its competitors.
A number of research analysts have recently issued reports on the company. BidaskClub lowered RTI Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. Zacks Investment Research upgraded RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, October 13th.
Shares of RTI Surgical (RTIX) traded down $0.13 during midday trading on Monday, hitting $4.75. 171,000 shares of the stock were exchanged, compared to its average volume of 190,073. The firm has a market cap of $296.56, a PE ratio of 121.88, a price-to-earnings-growth ratio of 6.50 and a beta of 1.73. RTI Surgical has a twelve month low of $2.81 and a twelve month high of $6.00. The company has a quick ratio of 1.21, a current ratio of 3.34 and a debt-to-equity ratio of 0.25.
RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, hitting analysts’ consensus estimates of $0.01. The business had revenue of $66.69 million for the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical had a net margin of 1.01% and a return on equity of 2.29%. The business’s revenue was up .2% compared to the same quarter last year. equities analysts forecast that RTI Surgical will post 0.05 EPS for the current year.
Large investors have recently made changes to their positions in the company. Cigna Investments Inc. New purchased a new position in shares of RTI Surgical during the 2nd quarter valued at approximately $105,000. Prudential Financial Inc. purchased a new position in shares of RTI Surgical during the 3rd quarter valued at approximately $111,000. Citadel Advisors LLC lifted its position in shares of RTI Surgical by 85.7% during the 3rd quarter. Citadel Advisors LLC now owns 26,786 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 12,361 shares in the last quarter. Citigroup Inc. lifted its position in shares of RTI Surgical by 2,850.1% during the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock valued at $124,000 after buying an additional 20,435 shares in the last quarter. Finally, First Quadrant L P CA purchased a new position in shares of RTI Surgical during the 2nd quarter valued at approximately $137,000. Hedge funds and other institutional investors own 68.37% of the company’s stock.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.